Rasagiline and Dopamine Interaction

Drug interaction information between Rasagiline and Dopamine.

Rasagiline and Dopamine have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Rasagiline and Dopamine. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Rasagiline

MAO-B Inhibitor

Drug B

Dopamine

Inotropic / Vasopressor

How They Interact

These two drugs work against each other in the brain, which can stop rasagiline from doing its job.

FDA Label Information

7.8 Dopaminergic Antagonists It is possible that dopamine antagonists, such as antipsychotics or metoclopramide, could diminish the effectiveness of rasagiline.

Frequently Asked Questions

What SPL severity band is on file for Rasagiline + Dopamine?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Dopamine has 28 labeled pairs on file vs Rasagiline's 7. In the minor band specifically: Rasagiline has 4 (also Ciprofloxacin, Norepinephrine, Metoclopramide); Dopamine has 23 (also Amitriptyline, Doxepin, Linezolid, Nortriptyline).

What mechanism field is on file for Rasagiline and Dopamine?

These two drugs work against each other in the brain, which can stop rasagiline from doing its job.

Dopamine's labeled portfolio outnumbers Rasagiline

SPL source-record counts only. This page's band is minor · classes on file: Rasagiline (MAO-B Inhibitor); Dopamine (Inotropic / Vasopressor).

Rasagiline

0 major · 3 moderate · 4 minor · 7 total

Dopamine

0 major · 5 moderate · 23 minor · 28 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.